Skip to main content
Log in

Evaluation of the susceptibility test of polymyxin B using the commercial test Policimbac®

  • Clinical Microbiology - Short Communication
  • Published:
Brazilian Journal of Microbiology Aims and scope Submit manuscript

Abstract

Broth microdilution (BMD), the reference method to determine bacterial susceptibility to polymyxins, is a laborious and time-consuming technique. Policimbac® is a commercial test panel which uses lyophilized polymyxin B to determine the minimum inhibitory concentration for Gram-negative isolates. This study evaluated the performance of Policimbac® in comparison with BMD for 110 isolates. Although the Policimbac® presented a very low essential agreement, the categorical agreement with BMD was optimal. Policimbac® is an alternative approach to BMD for evaluating the susceptibility to polymyxin B.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Falagas ME, Kasiakou SK, Saravolatz LD (2005) Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 40:1333–1341. https://doi.org/10.1086/429323

    Article  CAS  PubMed  Google Scholar 

  2. Lee J, Patel G, Huprikar S, Calfee DP, Jenkins SG (2009) Decreased susceptibility to polymyxin B during treatment for carbapenem-resistant Klebsiella pneumoniae infection. J Clin Microbiol 47:1611–1612. https://doi.org/10.1128/JCM.02466-08

    Article  PubMed  PubMed Central  Google Scholar 

  3. Nordmann P, Jayol A, Poirel L (2016) Rapid detection of polymyxin resistance in Enterobacteriaceae. Emerg Infect Dis 22:1038–1043. https://doi.org/10.3201/eid2206.151840

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Rahal JJ (2008) The role of carbapenems in initial therapy for serious gram-negative infections. Crit Care 12(4):S5–S7. https://doi.org/10.1186/cc6821

    Article  PubMed  PubMed Central  Google Scholar 

  5. Jeannot K, Bolard A, Plésiat P (2017) Resistance to polymyxins in gram-negative organisms. Int J Antimicrob Agents 49:526–535. https://doi.org/10.1016/j.ijantimicag.2016.11.029

    Article  CAS  PubMed  Google Scholar 

  6. Giamarellou H (2016) Epidemiology of infections caused by polymyxin-resistant pathogens. Int J Antimicrob Agents 48:614–621. https://doi.org/10.1016/j.ijantimicag.2016.09.025

    Article  CAS  PubMed  Google Scholar 

  7. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161–168. https://doi.org/10.1016/S1473-3099(15)00424-7

    Article  CAS  PubMed  Google Scholar 

  8. Conceição-Neto OC, Aires CAM, Pereira NF, da Silva LHJ, Picão RC, Siqueira BN, Albano RM, Asensi MD, Carvalho-Assef APD (2017) Detection of the plasmid-mediated mcr-1 gene in clinical KPC-2-producing Escherichia coli isolates in Brazil. Int J Antimicrob Agents 50:282–284. https://doi.org/10.1016/j.ijantimicag.2017.05.003

    Article  CAS  PubMed  Google Scholar 

  9. Dalmolin TV, Castro L, Mayer FQ, Zavascki AP, Martins AF, Lima-Morales D, Barth AL (2017) Co-occurrence of mcr-1 and blaKPC-2 in a clinical isolate of Escherichia coli in Brazil. J Antimicrob Chemother 72:2404–2406. https://doi.org/10.1093/jac/dkx142

    Article  CAS  PubMed  Google Scholar 

  10. Poirel L, Jayol A, Nordmann P (2017) Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev 30:557–596. https://doi.org/10.1128/CMR.00064-16

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lentz SA, de Lima-Morales D, Cuppertino VM, Nunes LS, da Motta AS, Zavascki AP, Barth AL, Martins AF (2016) Letter to editor: Escherichia coli harbouring mcr-1 gene isolated from poultry not exposed to polymyxins in Brazil. Euro Surveill 21(26). https://doi.org/10.2807/1560-7917

  12. Rozales FP, Ribeiro VB, Magagnin CM et al (2014) Emergence of NDM-1-producing Enterobacteriaceae in Porto Alegre, Brazil. Int J Infect Dis 25:79–81. https://doi.org/10.1016/j.ijid.2014.01.005

    Article  PubMed  Google Scholar 

  13. PROBAC. Policimbac®. Available from: http://probac.com.br/Anexos/Bulas/Meios%20Susceptibilidade/POLICIMBAC%20Rev%2004.pdf

  14. Brazilian Committee on Antimicrobial Susceptibility Testing (BrCAST). Breakpoints tables for interpretation of MICs and zone diameters. BrCAST 2018: Version 8.0

Download references

Funding

This work was supported in part by Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clínicas de Porto Alegre (FIPE/HCPA) (project no. 16-0559).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Afonso Luís Barth.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Responsible Editor: Mara Correa Lelles Nogueira.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dalmolin, T.V., Carneiro, M.d., de Castro, L.P. et al. Evaluation of the susceptibility test of polymyxin B using the commercial test Policimbac®. Braz J Microbiol 51, 1135–1137 (2020). https://doi.org/10.1007/s42770-020-00246-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42770-020-00246-9

Keywords

Navigation